Mundipharma fined for misleading advertising of opioids to health professionals
Published
Related content
-
Global Therapeutics fined $119,880 for alleged unlawful advertising of complementary medicines
Global Therapeutics Pty Ltd has paid penalties of $119,880 in response to nine infringement notices -
Tianda Pharmaceuticals fined $26,640 for alleged unlawful advertising of Anti-Epidemic Formula 1 in relation to COVID-19
The TGA has issued two infringement notices totalling $26,640 to Tianda Pharmaceuticals Australia Pty Ltd for alleged unlawful advertising of a listed medicine in relation to COVID-19. -
Multi-level marketing company fined $37,800 for alleged advertising breaches
Juice Plus Company Australia Pty Ltd has paid penalties of $37,800 for alleged advertising breaches relating to vitamin products